These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 21952670)

  • 1. Opposing efficacy of group III mGlu receptor activators, LSP1-2111 and AMN082, in animal models of positive symptoms of schizophrenia.
    Wierońska JM; Stachowicz K; Acher F; Lech T; Pilc A
    Psychopharmacology (Berl); 2012 Apr; 220(3):481-94. PubMed ID: 21952670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The antipsychotic-like effects of the mGlu group III orthosteric agonist, LSP1-2111, involves 5-HT₁A signalling.
    Wierońska JM; Acher FC; Sławińska A; Gruca P; Lasoń-Tyburkiewicz M; Papp M; Pilc A
    Psychopharmacology (Berl); 2013 Jun; 227(4):711-25. PubMed ID: 23474845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of GABAB Receptor Signaling in Antipsychotic-like Action of the Novel Orthosteric Agonist of the mGlu4 Receptor, LSP4-2022.
    Woźniak M; Acher F; Marciniak M; Lasoń-Tyburkiewicz M; Gruca P; Papp M; Pilc A; Wierońska JM
    Curr Neuropharmacol; 2016; 14(5):413-26. PubMed ID: 26769224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutual activation of glutamatergic mGlu
    Cieślik P; Woźniak M; Rook JM; Tantawy MN; Conn PJ; Acher F; Tokarski K; Kusek M; Pilc A; Wierońska JM
    Psychopharmacology (Berl); 2018 Oct; 235(10):2897-2913. PubMed ID: 30054675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the mGlu7 receptor elicits antidepressant-like effects in mice.
    Palucha A; Klak K; Branski P; van der Putten H; Flor PJ; Pilc A
    Psychopharmacology (Berl); 2007 Nov; 194(4):555-62. PubMed ID: 17622518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antipsychotic-like effects of positive allosteric modulators of metabotropic glutamate mGlu4 receptors in rodents.
    Sławińska A; Wierońska JM; Stachowicz K; Marciniak M; Lasoń-Tyburkiewicz M; Gruca P; Papp M; Kusek M; Tokarski K; Doller D; Pilc A
    Br J Pharmacol; 2013 Aug; 169(8):1824-39. PubMed ID: 23714045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral administration of group III mGlu receptor agonist ACPT-I exerts potential antipsychotic effects in rodents.
    Pałucha-Poniewiera A; Kłodzińska A; Stachowicz K; Tokarski K; Hess G; Schann S; Frauli M; Neuville P; Pilc A
    Neuropharmacology; 2008 Sep; 55(4):517-24. PubMed ID: 18619473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presynaptic mGlu7 receptors control GABA release in mouse hippocampus.
    Summa M; Di Prisco S; Grilli M; Usai C; Marchi M; Pittaluga A
    Neuropharmacology; 2013 Mar; 66():215-24. PubMed ID: 22564442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The reversal of cognitive, but not negative or positive symptoms of schizophrenia, by the mGlu₂/₃ receptor agonist, LY379268, is 5-HT₁A dependent.
    Wierońska JM; Sławińska A; Stachowicz K; Łasoń-Tyburkiewicz M; Gruca P; Papp M; Pilc A
    Behav Brain Res; 2013 Nov; 256():298-304. PubMed ID: 23948211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antidepressant-like action of metabotropic glutamate 7 receptor agonist N,N'-bis(diphenylmethyl)-1,2-ethanediamine (AMN082) is serotonin-dependent.
    Pałucha-Poniewiera A; Brański P; Lenda T; Pilc A
    J Pharmacol Exp Ther; 2010 Sep; 334(3):1066-74. PubMed ID: 20562216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of AMN082, metabotropic glutamate receptor 7 (mGlu7) allosteric agonist on the acute and chronic antinociceptive effects of morphine in the tail-immersion test in mice: Comparison with mGlu5 and mGlu2/3 ligands.
    Gawel K; Jenda-Wojtanowska M; Gibula-Bruzda E; Kedzierska E; Filarowska J; Marszalek-Grabska M; Wojtanowski KK; Komsta L; Talarek S; Kotlinska JH
    Physiol Behav; 2018 Mar; 185():112-120. PubMed ID: 29294304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential antidepressant action and adverse effects profile of scopolamine co-administered with the mGlu7 receptor allosteric agonist AMN082 in mice.
    Podkowa K; Pilc A; Podkowa A; Sałat K; Marciniak M; Pałucha-Poniewiera A
    Neuropharmacology; 2018 Oct; 141():214-222. PubMed ID: 30145321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel mGlu4 selective agonist LSP4-2022 increases behavioral despair in mouse models of antidepressant action.
    Podkowa K; Rzeźniczek S; Marciniak M; Acher F; Pilc A; Pałucha-Poniewiera A
    Neuropharmacology; 2015 Oct; 97():338-45. PubMed ID: 26074092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel role for the metabotropic glutamate receptor-7: modulation of faecal water content and colonic electrolyte transport in the mouse.
    Julio-Pieper M; Hyland NP; Bravo JA; Dinan TG; Cryan JF
    Br J Pharmacol; 2010 May; 160(2):367-75. PubMed ID: 20423346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurochemical and behavioral studies on the 5-HT
    Woźniak M; Gołembiowska K; Noworyta-Sokołowska K; Acher F; Cieślik P; Kusek M; Tokarski K; Pilc A; Wierońska JM
    Neuropharmacology; 2017 Mar; 115():149-165. PubMed ID: 27465045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The antipsychotic-like effects in rodents of the positive allosteric modulator Lu AF21934 involve 5-HT1A receptor signaling: mechanistic studies.
    Wierońska JM; Sławińska A; Łasoń-Tyburkiewicz M; Gruca P; Papp M; Zorn SH; Doller D; Kłeczek N; Noworyta-Sokołowska K; Gołembiowska K; Pilc A
    Psychopharmacology (Berl); 2015 Jan; 232(1):259-73. PubMed ID: 25012236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabotropic glutamate receptor 4 novel agonist LSP1-2111 with anxiolytic, but not antidepressant-like activity, mediated by serotonergic and GABAergic systems.
    Wierońska JM; Stachowicz K; Pałucha-Poniewiera A; Acher F; Brański P; Pilc A
    Neuropharmacology; 2010 Dec; 59(7-8):627-34. PubMed ID: 20713068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabotropic glutamate 7 receptor subtype modulates motor symptoms in rodent models of Parkinson's disease.
    Greco B; Lopez S; van der Putten H; Flor PJ; Amalric M
    J Pharmacol Exp Ther; 2010 Mar; 332(3):1064-71. PubMed ID: 19940105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and Synthesis of New Quinazolin-4-one Derivatives with Negative mGlu
    Kaczorowska K; Stankiewicz A; Bugno R; Paluchowska MH; Burnat G; Brański P; Cieślik P; Wierońska JM; Milik M; Nowak M; Przybyłowicz A; Kozioł A; Hogendorf A; Hogendorf AS; Kalinowska-Tłuścik J; Duszyńska B; Pilc A; Bojarski AJ
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the mTOR signaling pathway in the antidepressant-like activity of the mGlu5 antagonist MTEP and the mGlu7 agonist AMN082 in the FST in rats.
    Pałucha-Poniewiera A; Szewczyk B; Pilc A
    Neuropharmacology; 2014 Jul; 82():59-68. PubMed ID: 24631968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.